COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN AUSTRIA

被引：4
|
作者：
Walter, E. [1 ]
Bauer, M. [1 ]
Ressl, S. [1 ]
机构：
[1] Inst Pharmaecon Res, Vienna, Austria
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.876
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV107
引用
收藏
页码：A392 / A392
页数：1
相关论文
共 50 条
  • [21] Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
    Eun-A Lim
    Hyun-Soon Sohn
    Haeyoung Lee
    Sang-Eun Choi
    Cost Effectiveness and Resource Allocation, 12
  • [22] BUDGET IMPACT OF IV IRON THERAPY WITH FERRIC CARBOXYMALTOSE IN PATIENTS WITH CHRONIC HEART FAILURE AND IRON DEFICIENCY IN FRANCE
    Bourvignon, S.
    Levesque, K.
    Faller, M.
    Champs, R.
    Gremaud, N.
    Moutier, H.
    Caranhac, G.
    Cohen-Solal, A.
    VALUE IN HEALTH, 2017, 20 (09) : A607 - A607
  • [23] Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea
    Lim, Eun-A
    Sohn, Hyun-Soon
    Lee, Haeyoung
    Choi, Sang-Eun
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2014, 12
  • [24] FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE FROM THE PERSPECTIVE OF PRIVATE HEALTH CARE SYSTEM: COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT IN BRAZIL
    Campagnaro, M.
    Picoli, R. M.
    Castelano, N.
    Clemente, V
    Serna, Ramirez de Arellano A.
    VALUE IN HEALTH, 2023, 26 (12) : S111 - S111
  • [25] COST-EFFECTIVENESS OF FERRIC CARBOXYMALTOSE (FCM) IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Walter, E.
    Lazic-Peric, A.
    Schalle, K.
    VALUE IN HEALTH, 2017, 20 (09) : A634 - A635
  • [26] COST-EFFECTIVENESS ANALYSIS OF FERRIC MALTOL VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN IBD PATIENTS IN SWEDEN AND FINLAND
    Hjelmgren, J.
    Ericson, O.
    Niska, P.
    Kukkonen, P.
    Birgegard, G.
    VALUE IN HEALTH, 2018, 21 : S452 - S453
  • [27] IV Ferric Carboxymaltose (Injectafer) for Iron Deficiency in Heart Failure
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1695): : 22 - 24
  • [28] COST-EFFECTIVENESS ANALYSIS OF FERRIC CARBOXYMALTOSE VERSUS IRON SUCROSE FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SPAIN
    Arguelles, F.
    Bermejo, F.
    Borras Blasco, J.
    Domenech, E.
    Sicilia, B.
    Huguet, J. M.
    Serna, Ramirez de Arellano A.
    Valentine, W.
    Hunt, B.
    VALUE IN HEALTH, 2022, 25 (01) : S95 - S95
  • [29] Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain
    Arguelles-Arias, Federico
    Bermejo, Fernando
    Borras-Blasco, Joaquin
    Domenech, Eugeni
    Sicilia, Beatriz
    Huguet, Jose M.
    de Arellano, Antonio Ramirez
    Valentine, William J.
    Hunt, Barnaby
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [30] Assessing the Effectiveness of Ferric Carboxymaltose for Treating Iron Deficiency in Heart Failure Patients Along with its Effect on Clinical Parameters
    Gajbhiye, Drumadala
    Younus, Shifa
    Cheema, Muhammad Hussnain
    Cheema, Muhammad Hassan
    Fatima, Noor
    Zafar, Aeman
    Ali, Aamir
    Hussain, Alamdar
    Hussain, Tauseef
    Choudhary, Humais
    CIRCULATION, 2024, 150
12345